NTLA : Intellia Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-05-09 |
|---|---|---|---|---|
| 2022 | $41.85 | $40.32 | $45.46 | 0.97% |
| 2023 | $70.35 | $48.35 | $85.13 | 69.73% |
| 2024 | $85.07 | $82.88 | $86.62 | 105.25% |
| 2025 | $99.01 | $83.33 | $116.96 | 138.88% |
| 2026 | $117.58 | $116.08 | $120.12 | 183.68% |
| 2027 | $121.93 | $120.34 | $122.91 | 194.16% |
| 2028 | $114.04 | $106.14 | $119.37 | 175.12% |
| 2029 | $85.48 | $65.11 | $104.76 | 106.22% |
| 2030 | $58.8 | $52.7 | $64.38 | 41.87% |
| 2031 | $47.29 | $42.14 | $51.85 | 14.1% |
| 2032 | $40.28 | $39.35 | $41.37 | -2.83% |
From AI system, total return is 2800.78% from 3414 forecasts.
For Intellia Therapeutics stock forecast for 2022, 7 predictions are offered for each month of 2022 with average Intellia Therapeutics stock
forecast of $41.85, a high forecast of $45.46, and a low forecast of $40.32.
The average Intellia Therapeutics stock forecast 2022 represents a 0.97%
increase from the last price of $41.4500007629395.
For Intellia Therapeutics stock forecast for 2023, 12 predictions are offered for each month of 2023 with average Intellia Therapeutics stock
forecast of $70.35, a high forecast of $85.13, and a low forecast of $48.35.
The average Intellia Therapeutics stock forecast 2023 represents a 69.73%
increase from the last price of $41.4500007629395.
For Intellia Therapeutics stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Intellia Therapeutics stock
forecast of $99.01, a high forecast of $116.96, and a low forecast of $83.33.
The average Intellia Therapeutics stock forecast 2025 represents a 138.88%
increase from the last price of $41.4500007629395.
For Intellia Therapeutics stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Intellia Therapeutics stock
forecast of $121.93, a high forecast of $122.91, and a low forecast of $120.34.
The average Intellia Therapeutics stock forecast 2027 represents a 194.16%
increase from the last price of $41.4500007629395.
For Intellia Therapeutics stock forecast for 2030, 12 predictions are offered for each month of 2030 with average Intellia Therapeutics stock
forecast of $58.8, a high forecast of $64.38, and a low forecast of $52.7.
The average Intellia Therapeutics stock forecast 2030 represents a 41.87%
increase from the last price of $41.4500007629395.
For Intellia Therapeutics stock forecast for 2032 (10 year), 5 predictions are offered for each month of 2032 with average Intellia Therapeutics stock
forecast of $40.28, a high forecast of $41.37, and a low forecast of $39.35.
The average Intellia Therapeutics stock forecast 2032 represents a -2.83%
decrease from the last price of $41.4500007629395.
Please, see more forecasts below.
NTLA : Intellia Therapeutics stock forecast by Wall Street Analysts
Intellia Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-05-10 | $39.77 | -4.05% |
| 2022-05-11 | $40.45 | 1.70% |
| 2022-05-12 | $41.70 | 3.10% |
| 2022-05-13 | $42.65 | 2.27% |
| 2022-05-16 | $42.89 | 0.56% |
NTLA : Long term Intellia Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Jun. is $40.82 , for 2023 May. is $66.41 , for 2026 May. is $116.08 , for 2027 May. is $121.84 , for 2031 May. is $49.02 , and for 2032 May. is $39.35.
NTLA : Intellia Therapeutics stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Jun. | $40.82 | -1.52% |
| 2022 Jul. | $40.34 | -1.19% |
| 2022 Aug. | $40.32 | -0.04% |
| 2022 Sep. | $40.82 | 1.26% |
| 2022 Oct. | $41.84 | 2.50% |
| 2022 Nov. | $43.36 | 3.63% |
| 2022 Dec. | $45.46 | 4.84% |
NTLA : Intellia Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $48.35 | 6.35% |
| 2023 Feb. | $52.26 | 8.10% |
| 2023 Mar. | $56.85 | 8.78% |
| 2023 Apr. | $61.63 | 8.41% |
| 2023 May. | $66.41 | 7.76% |
| 2023 Jun. | $71.31 | 7.38% |
| 2023 Jul. | $75.48 | 5.84% |
| 2023 Aug. | $78.71 | 4.28% |
| 2023 Sep. | $81.08 | 3.02% |
| 2023 Oct. | $82.80 | 2.12% |
| 2023 Nov. | $84.23 | 1.72% |
| 2023 Dec. | $85.13 | 1.08% |
NTLA : Intellia Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $85.74 | 0.71% |
| 2024 Feb. | $86.18 | 0.52% |
| 2024 Mar. | $86.48 | 0.35% |
| 2024 Apr. | $86.62 | 0.15% |
| 2024 May. | $86.47 | -0.17% |
| 2024 Jun. | $86.07 | -0.46% |
| 2024 Jul. | $85.37 | -0.81% |
| 2024 Aug. | $84.55 | -0.96% |
| 2024 Sep. | $83.93 | -0.74% |
| 2024 Oct. | $83.48 | -0.53% |
| 2024 Nov. | $83.12 | -0.44% |
| 2024 Dec. | $82.88 | -0.28% |
NTLA : Intellia Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $83.33 | 0.54% |
| 2025 Feb. | $84.43 | 1.32% |
| 2025 Mar. | $86.18 | 2.07% |
| 2025 Apr. | $88.60 | 2.81% |
| 2025 May. | $91.73 | 3.53% |
| 2025 Jun. | $95.49 | 4.10% |
| 2025 Jul. | $99.78 | 4.49% |
| 2025 Aug. | $104.41 | 4.64% |
| 2025 Sep. | $108.93 | 4.33% |
| 2025 Oct. | $112.79 | 3.54% |
| 2025 Nov. | $115.53 | 2.43% |
| 2025 Dec. | $116.96 | 1.24% |
NTLA : Intellia Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $117.45 | 0.41% |
| 2026 Feb. | $117.23 | -0.18% |
| 2026 Mar. | $116.74 | -0.42% |
| 2026 Apr. | $116.30 | -0.38% |
| 2026 May. | $116.08 | -0.19% |
| 2026 Jun. | $116.14 | 0.06% |
| 2026 Jul. | $116.63 | 0.42% |
| 2026 Aug. | $117.08 | 0.38% |
| 2026 Sep. | $117.68 | 0.51% |
| 2026 Oct. | $119.55 | 1.59% |
| 2026 Nov. | $120.00 | 0.38% |
| 2026 Dec. | $120.12 | 0.10% |
NTLA : Intellia Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $121.39 | 1.06% |
| 2027 Feb. | $122.24 | 0.70% |
| 2027 Mar. | $122.19 | -0.04% |
| 2027 Apr. | $121.89 | -0.25% |
| 2027 May. | $121.84 | -0.04% |
| 2027 Jun. | $122.02 | 0.15% |
| 2027 Jul. | $122.33 | 0.26% |
| 2027 Aug. | $122.74 | 0.33% |
| 2027 Sep. | $122.91 | 0.14% |
| 2027 Oct. | $122.08 | -0.67% |
| 2027 Nov. | $121.17 | -0.75% |
| 2027 Dec. | $120.34 | -0.68% |
NTLA : Intellia Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $119.37 | -0.81% |
| 2028 Feb. | $118.35 | -0.86% |
| 2028 Mar. | $117.53 | -0.69% |
| 2028 Apr. | $116.93 | -0.51% |
| 2028 May. | $116.33 | -0.51% |
| 2028 Jun. | $115.60 | -0.63% |
| 2028 Jul. | $114.73 | -0.76% |
| 2028 Aug. | $113.63 | -0.96% |
| 2028 Sep. | $112.05 | -1.40% |
| 2028 Oct. | $109.96 | -1.86% |
| 2028 Nov. | $107.80 | -1.96% |
| 2028 Dec. | $106.14 | -1.54% |
NTLA : Intellia Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $104.76 | -1.30% |
| 2029 Feb. | $103.15 | -1.54% |
| 2029 Mar. | $101.07 | -2.01% |
| 2029 Apr. | $98.40 | -2.64% |
| 2029 May. | $94.85 | -3.61% |
| 2029 Jun. | $90.01 | -5.11% |
| 2029 Jul. | $83.84 | -6.86% |
| 2029 Aug. | $77.48 | -7.58% |
| 2029 Sep. | $72.22 | -6.79% |
| 2029 Oct. | $68.51 | -5.14% |
| 2029 Nov. | $66.31 | -3.22% |
| 2029 Dec. | $65.11 | -1.81% |
NTLA : Intellia Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $64.38 | -1.11% |
| 2030 Feb. | $63.78 | -0.95% |
| 2030 Mar. | $63.12 | -1.02% |
| 2030 Apr. | $62.29 | -1.33% |
| 2030 May. | $60.94 | -2.16% |
| 2030 Jun. | $59.27 | -2.74% |
| 2030 Jul. | $57.97 | -2.19% |
| 2030 Aug. | $56.91 | -1.83% |
| 2030 Sep. | $55.85 | -1.86% |
| 2030 Oct. | $54.75 | -1.97% |
| 2030 Nov. | $53.67 | -1.97% |
| 2030 Dec. | $52.70 | -1.82% |
NTLA : Intellia Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $51.85 | -1.60% |
| 2031 Feb. | $51.12 | -1.42% |
| 2031 Mar. | $50.44 | -1.32% |
| 2031 Apr. | $49.77 | -1.33% |
| 2031 May. | $49.02 | -1.51% |
| 2031 Jun. | $48.13 | -1.83% |
| 2031 Jul. | $47.10 | -2.13% |
| 2031 Aug. | $46.02 | -2.29% |
| 2031 Sep. | $44.96 | -2.30% |
| 2031 Oct. | $43.96 | -2.24% |
| 2031 Nov. | $43.01 | -2.16% |
| 2031 Dec. | $42.14 | -2.02% |
NTLA : Intellia Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $41.37 | -1.84% |
| 2032 Feb. | $40.71 | -1.60% |
| 2032 Mar. | $40.18 | -1.29% |
| 2032 Apr. | $39.79 | -0.99% |
| 2032 May. | $39.35 | -1.10% |
Financial Data for Intellia Therapeutics stock
Frequently Asked Questions about Intellia Therapeutics stock forecast
Is Intellia Therapeutics a good long term stock?
From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2022 Jun. is $40.8211101211518 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2023 May. is $66.4093232066379 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2026 May. is $116.077873248875 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2027 May. is $121.839096571948 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2031 May. is $49.0231065961503 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2032 May. is $39.346431538833
Is Intellia Therapeutics stock overvalued?
Intellia Therapeutics (NTLA) stock is expected to go UP . Therefore, AI Pickup would say that Intellia Therapeutics (NTLA) stock is NOT overvalued.
Will Intellia Therapeutics stock price go up?
Yes. The Intellia Therapeutics stock price forecast for 2023 May. is $66.4093232066379
Is Intellia Therapeutics stock a good buy now?
Since closing price on 2022-05-09 is $41.4500007629395 and forecast for 2023 May. is $66.41, Intellia Therapeutics stock is a good 1 year investment.